China
Name: Beijing Xiangxin Biotechnology Co., Ltd.
Slogan: "Dual-core driving of entity and blood, leading the future of precision medicine transformation"
Description: Beijing Xiangxin Biotechnology is a global leader in tumor molecular diagnostics and research transformation services. With a comprehensive industry team and deep technical reserves, the company is committed to providing comprehensive solutions for personalized diagnosis and treatment, recurrence monitoring, and early screening for cancer patients. The company's vision is to deeply explore genomic information so that every patient can benefit from precise diagnosis, treatment, and monitoring of tumors. Its mission is to focus on precision diagnosis and research result transformation for tumors while respecting science, caring for life, serving customers, and achieving mutual success as its core values.
Founded: 2017
Headquarter: China
Last Investment: CNY200.00M Series B investment at 27 December 2022
Last Investment Investors: N/A
